Total Payments
$4,911
2022 Payments
$205.65
Companies
26
Transactions
377
Medicare Patients
889
Medicare Billing
$127,176
Payment Breakdown by Category
Food & Beverage$4,911 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,911 | 377 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,026 | 85 | $0 (2021) |
| Gilead Sciences, Inc. | $764.88 | 80 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $571.12 | 36 | $0 (2020) |
| AbbVie Inc. | $371.68 | 29 | $0 (2020) |
| PFIZER INC. | $315.54 | 23 | $0 (2020) |
| Allergan Inc. | $302.84 | 24 | $0 (2018) |
| Janssen Biotech, Inc. | $282.07 | 26 | $0 (2021) |
| W. L. Gore & Associates, Inc. | $188.66 | 2 | $0 (2022) |
| Valeant Pharmaceuticals North America LLC | $187.92 | 9 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $133.86 | 12 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $205.65 | 2 | W. L. Gore & Associates, Inc. ($175.00) |
| 2021 | $410.55 | 33 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($234.70) |
| 2020 | $606.06 | 51 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($248.78) |
| 2019 | $1,074 | 98 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($265.03) |
| 2018 | $1,319 | 113 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($277.06) |
| 2017 | $1,296 | 80 | Gilead Sciences Inc ($258.89) |
All Payment Transactions
377 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2022 | W. L. Gore & Associates, Inc. | Product in Development (Device) | Food and Beverage | In-kind items and services | $175.00 | General |
| Category: Devices | ||||||
| 04/20/2022 | Becton, Dickinson and Company | — | Food and Beverage | In-kind items and services | $30.65 | General |
| 06/16/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Gastroenterology | ||||||
| 06/09/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: Gastroenterology | ||||||
| 05/11/2021 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: Immunology | ||||||
| 05/04/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Gastroenterology | ||||||
| 05/04/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Gastroenterology | ||||||
| 05/04/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Gastroenterology | ||||||
| 05/04/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Gastroenterology | ||||||
| 05/04/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Gastroenterology | ||||||
| 05/04/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $6.24 | General |
| Category: Gastroenterology | ||||||
| 05/04/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $4.35 | General |
| Category: Gastroenterology | ||||||
| 04/29/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $1.15 | General |
| Category: Gastroenterology | ||||||
| 04/21/2021 | W. L. Gore & Associates, Inc. | GORE CARDIOFORM Septal Occluder (Device) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Devices | ||||||
| 04/14/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.80 | General |
| 04/06/2021 | Braintree Laboratories, Inc. | SUTAB (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: GI COLON PREP | ||||||
| 03/10/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.00 | General |
| 02/24/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.13 | General |
| 02/17/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Gastroenterology | ||||||
| 02/17/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Gastroenterology | ||||||
| 02/17/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: Gastroenterology | ||||||
| 02/17/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Gastroenterology | ||||||
| 02/16/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: Gastroenterology | ||||||
| 02/16/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $10.27 | General |
| Category: Gastroenterology | ||||||
| 02/16/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $6.15 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 6 | 273 | 333 | $490,517 | $39,989 |
| 2020 | 11 | 616 | 793 | $398,847 | $87,187 |
Total Patients
889
Total Services
1,126
Medicare Billing
$127,176
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 145 | 205 | $150,880 | $20,084 | 13.3% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2021 | 32 | 32 | $73,792 | $6,411 | 8.7% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 19 | 19 | $58,786 | $4,293 | 7.3% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 40 | 40 | $105,960 | $3,717 | 3.5% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 23 | 23 | $68,839 | $3,622 | 5.3% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 14 | 14 | $32,260 | $1,862 | 5.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 254 | 410 | $99,630 | $35,619 | 35.8% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 104 | 105 | $85,575 | $9,949 | 11.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2020 | 43 | 43 | $45,365 | $9,036 | 19.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Facility | 2020 | 29 | 29 | $39,150 | $6,612 | 16.9% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 37 | 37 | $42,550 | $5,894 | 13.9% |
| 45378 | Diagnostic examination of large bowel using an endoscope | Facility | 2020 | 34 | 34 | $35,870 | $5,216 | 14.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2020 | 23 | 23 | $24,265 | $4,803 | 19.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 34 | 34 | $12,444 | $4,297 | 34.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 17 | 27 | $6,129 | $2,415 | 39.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 24 | 33 | $4,863 | $2,171 | 44.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 17 | 18 | $3,006 | $1,178 | 39.2% |
About Dr. William Sloan, M.D
Dr. William Sloan, M.D is a Gastroenterology healthcare provider based in West Orange, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1578750204.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Sloan, M.D has received a total of $4,911 in payments from pharmaceutical and medical device companies, with $205.65 received in 2022. These payments were reported across 377 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($4,911).
As a Medicare-enrolled provider, Sloan has provided services to 889 Medicare beneficiaries, totaling 1,126 services with total Medicare billing of $127,176. Data is available for 2 years (2020–2021), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location West Orange, NJ
- Active Since 09/26/2007
- Last Updated 09/08/2014
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1578750204
Products in Payments
- XIFAXAN (Drug) $868.68
- XELJANZ (Drug) $281.90
- LINZESS (Drug) $281.21
- ZEPATIER (Drug) $257.14
- UCERIS (Drug) $242.86
- STELARA (Biological) $237.07
- Product in Development (Device) $175.00
- DIFICID (Drug) $164.36
- Humira (Biological) $138.85
- INJECTAFER (Drug) $108.94
- Entyvio (Biological) $107.34
- Creon (Drug) $103.32
- Amitiza (Drug) $96.07
- NOXAFIL (Drug) $94.64
- Trulance (Drug) $92.23
- Mavyret (Drug) $78.22
- OCA (Drug) $63.19
- TRULANCE (Drug) $60.40
- SUPREP (Drug) $54.02
- REMICADE (Biological) $45.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in West Orange
Dr. Alexander Perelman, D.o, D.O
Gastroenterology — Payments: $99,250
Gastroenterology $99,250
Robert Schuman, Md, MD
Gastroenterology — Payments: $44,812
Gastroenterology $44,812
Matthew Askin, M.d, M.D
Gastroenterology — Payments: $14,388
Gastroenterology $14,388
Dr. Lawrence Rosenthal, M.d, M.D
Gastroenterology — Payments: $11,431
Gastroenterology $11,431
Dr. Andrew Stefaniwsky, M.d, M.D
Gastroenterology — Payments: $6,822
Gastroenterology $6,822
Dr. Robert Ruffini, M.d, M.D
Gastroenterology — Payments: $4,479
Gastroenterology $4,479